Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 4 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 207Neoplasms 130Polycystic Ovary Syndrome 107Carcinoma, Hepatocellular 82Colorectal Neoplasms 77Prostatic Neoplasms 70Stomach Neoplasms 55Lung Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 41Pain, Postoperative 41Head and Neck Neoplasms 38Pain 37Liver Neoplasms 36Leukemia, Myeloid, Acute 32Leiomyoma 32Keratosis, Actinic 31Colonic Neoplasms 31Recurrence 30Neoplasm Metastasis 29Multiple Myeloma 28Infertility 28Brain Neoplasms 28Uterine Cervical Neoplasms 26Urinary Bladder Neoplasms 24Ovarian Neoplasms 24Lymphoma 24Esophageal Neoplasms 23Obesity 22

Interventions

Uterine Artery Embolization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Pelvic Pain × Clear all
NCT05538689 2025-09-29

SOUL

University of Chicago

Phase 4 Withdrawn

Leiomyoma, Menorrhagia, Metrorrhagia, Pelvic Pain

NCT00995878 2018-01-12

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

Mayo Clinic

Phase 4 Completed
56 enrolled

Leiomyoma, Myoma, Pelvic Pain, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡